Biogen shares soar as FDA reviewers support Alzheimer’s drug
MELBOURNE: Biogen’s experimental Alzheimer’s disease therapy appears effective despite conflicting clinical-trial results, according ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
